Bae YH - Search Results

1

BYL719, a selective inhibitor of phosphoinositide 3-Kinase α, enhances the effect of selumetinib (AZD6244, ARRY-142886) in KRAS-mutant non-small cell lung cancer.

Ku BM, Jho EH, Bae YH, Sun JM, Ahn JS, Park K, Ahn MJ. Ku BM, et al. Among authors: bae yh. Invest New Drugs. 2015 Feb;33(1):12-21. doi: 10.1007/s10637-014-0163-9. Epub 2014 Oct 25. Invest New Drugs. 2015. PMID: 25342139

2

Entrectinib resistance mechanisms in ROS1-rearranged non-small cell lung cancer.

Ku BM, Bae YH, Lee KY, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ. Ku BM, et al. Among authors: bae yh. Invest New Drugs. 2020 Apr;38(2):360-368. doi: 10.1007/s10637-019-00795-3. Epub 2019 May 24. Invest New Drugs. 2020. PMID: 31124056 Free PMC article.

3

A Phase Ib/II Study of Afatinib in Combination with Nimotuzumab in Non-Small Cell Lung Cancer Patients with Acquired Resistance to Gefitinib or Erlotinib.

Lee JY, Sun JM, Lim SH, Kim HS, Yoo KH, Jung KS, Song HN, Ku BM, Koh J, Bae YH, Lee SH, Ahn JS, Park K, Ahn MJ. Lee JY, et al. Among authors: bae yh. Clin Cancer Res. 2016 May 1;22(9):2139-45. doi: 10.1158/1078-0432.CCR-15-1653. Epub 2015 Dec 14. Clin Cancer Res. 2016. PMID: 26667485 Clinical Trial.

4

The CDK4/6 inhibitor LY2835219 has potent activity in combination with mTOR inhibitor in head and neck squamous cell carcinoma.

Ku BM, Yi SY, Koh J, Bae YH, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ. Ku BM, et al. Among authors: bae yh. Oncotarget. 2016 Mar 22;7(12):14803-13. doi: 10.18632/oncotarget.7543. Oncotarget. 2016. PMID: 26909611 Free PMC article.

5

AZD9291 overcomes T790 M-mediated resistance through degradation of EGFR(L858R/T790M) in non-small cell lung cancer cells.

Ku BM, Bae YH, Koh J, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ. Ku BM, et al. Among authors: bae yh. Invest New Drugs. 2016 Aug;34(4):407-15. doi: 10.1007/s10637-016-0350-y. Epub 2016 Apr 5. Invest New Drugs. 2016. PMID: 27044261

6

Mutational status of TP53 defines the efficacy of Wee1 inhibitor AZD1775 in KRAS-mutant non-small cell lung cancer.

Ku BM, Bae YH, Koh J, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ. Ku BM, et al. Among authors: bae yh. Oncotarget. 2017 Jun 28;8(40):67526-67537. doi: 10.18632/oncotarget.18728. eCollection 2017 Sep 15. Oncotarget. 2017. PMID: 28978051 Free PMC article.

7

MDSC subtypes and CD39 expression on CD8⁺ T cells predict the efficacy of anti-PD-1 immunotherapy in patients with advanced NSCLC.

Koh J, Kim Y, Lee KY, Hur JY, Kim MS, Kim B, Cho HJ, Lee YC, Bae YH, Ku BM, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ. Koh J, et al. Among authors: bae yh. Eur J Immunol. 2020 Nov;50(11):1810-1819. doi: 10.1002/eji.202048534. Epub 2020 Jul 9. Eur J Immunol. 2020. PMID: 32510574 Free PMC article.

8

Vascular calcifying progenitor cells possess bidirectional differentiation potentials.

Cho HJ, Cho HJ, Lee HJ, Song MK, Seo JY, Bae YH, Kim JY, Lee HY, Lee W, Koo BK, Oh BH, Park YB, Kim HS. Cho HJ, et al. Among authors: bae yh. PLoS Biol. 2013;11(4):e1001534. doi: 10.1371/journal.pbio.1001534. Epub 2013 Apr 9. PLoS Biol. 2013. PMID: 23585735 Free PMC article.

9

Extracellular Vesicles Generated Using Bioreactors and their Therapeutic Effect on the Acute Kidney Injury Model.

Kang H, Bae YH, Kwon Y, Kim S, Park J. Kang H, et al. Among authors: bae yh. Adv Healthc Mater. 2022 Feb;11(4):e2101606. doi: 10.1002/adhm.202101606. Epub 2021 Nov 23. Adv Healthc Mater. 2022. PMID: 34773445

10

Structural Equation Modeling of Person-Centered Nursing in Hospital Nurses.

Bae YH, Yeom HA. Bae YH, et al. Healthcare (Basel). 2022 Mar 11;10(3):514. doi: 10.3390/healthcare10030514. Healthcare (Basel). 2022. PMID: 35326991 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

300 results

Search Page

Filters